Ajanta Pharma Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 38,358 shares,. Its Average Traded Price (ATP) is ₹3345.03, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹3329.00.
Ajanta Pharma has an upper circuit limit of ₹3994.80 and a lower circuit limit of ₹2663.20. The total value traded stands at ₹12.83 CR, and the delivery percentage for the day is 54.69%.
The stock is currently traded with a market lot size of 1. Ajanta Pharma also offers a dividend yield of 0.84%.
Ajanta Pharma Share Price Chart
Ajanta Pharma Share Key Metrics
Volume
38358.00
Market Cap
41598.86 CR
LTQ@LTP
1@3329.00
ATP
3345.03
Var Margin
14.47 %
Circuit Range
2663.2-3994.8
Delivery %
54.69 %
Value
12.83 CR
ASM/GSM
No
Market Lot
1
Ajanta Pharma Resistance and Support
Pivot 3353.6
Resistance
First Resistance
3393.5
Second Resistance
3427.6
Third Resistance
3467.5
Support
First Support
3319.5
Second Support
3279.6
Third Support
3245.5
Ajanta Pharma Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2021-22
- 2020-21
- 2025-26
- 2024-25
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Ajanta Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results & Interim Dividend |
| 2026-05-05 | Audited Results |
| 2026-01-30 | Quarterly Results |
| 2025-11-03 | Quarterly Results & Interim Dividend |
| 2025-07-28 | Quarterly Results & Others |
| 2025-04-30 | Audited Results & A.G.M. |
| 2025-01-30 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-05 | 2026-08-05 | View More |
Ajanta Pharma News
Ajanta Pharma Ltd - 532331 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027
Ajanta Pharma board will meet on 30 October 2026 for financial results.
Oct 15 2026 10:28:19
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Promoter Aayush Agrawal Trust has created a pledge on 4.60 lakh shares (0.37% of total share capital) of Ajanta Pharma. The pledge was created in favor of CTL Trusteeship Ltd for the issuance of NCDs, taking the total encumbered holding of the trust to 9.69%.
Oct 06 2026 10:32:54
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter group entities of Ajanta Pharma have pledged an additional 2.1% stake (26.2 lakh shares) to CTL Trusteeship Limited. With this transaction, the total pledged promoter holding in the company increases from 5.31% to 7.41%.
Oct 01 2026 13:10:18
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma's promoter, Aayush Agrawal (Trustee Aayush Agrawal Trust), released a pledge on 17.36 lakh equity shares. This action was attributed to loan repayment, decreasing the overall promoter pledged holding.
Sep 18 2026 16:31:55
Ajanta Pharma Management
| Name | Position |
|---|---|
| Gaurang Shah | Sr. VP – Legal, Company Secretary & Compliance Officer |
| Mannalal B Agrawal | Chairman |
Ajanta Pharma Similar Stocks
Abbott India Ltd.
26170.00
100.00 (0.38%)
Gland Pharma Ltd.
3043.40
-22.90 (0.75%)
Ipca Laboratories Ltd.
1832.60
-80.50 (4.21%)
Anthem Biosciences Ltd.
822.15
-19.95 (2.37%)
Glaxosmithkline Pharmaceuticals Ltd.
2566.10
41.40 (1.64%)
Emcure Pharmaceuticals Ltd.
1820.60
-15.40 (0.84%)
Narayana Hrudayalaya Ltd.
1719.40
-6.00 (0.35%)
Global Health Ltd.
1240.00
-35.50 (2.78%)
Ajanta Pharma FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AJANTPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AJANTPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade